Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 2/20 | 0.55 |
| ▸ | MAG | P20916 | 5/20 | 0.55 |
| ▸ | NANP | Q8TBE9 | 1/20 | 0.53 |
| ▸ | SELL | P14151 | 1/20 | 0.52 |
| ▸ | SELP | P16109 | 1/20 | 0.52 |
| ▸ | CD22 | P20273 | 12/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29352702 | 1.00 | SIGLEC7 (0.55) | SIGLEC7MAGNANPSELLSELP | |
| SCHEMBL29410578 | 1.00 | SIGLEC7 (0.55) | SIGLEC7MAGNANPSELLSELP | |
| SCHEMBL15177450 | 1.00 | SIGLEC7 (0.55) | SIGLEC7MAGNANPSELLSELP | |
| SCHEMBL16298815 | 1.00 | SIGLEC7 (0.55) | SIGLEC7MAGNANPSELLSELP | |
| SCHEMBL31309218 | 0.94 | SIGLEC7 (0.57) | SIGLEC7MAGNANPSELLSELP | |
| SCHEMBL29437857 | 0.94 | SIGLEC7 (0.57) | SIGLEC7MAGNANPSELLSELP | |
| SCHEMBL29437858 | 0.94 | SIGLEC7 (0.57) | SIGLEC7MAGNANPSELLSELP | |
| SCHEMBL29397098 | 0.94 | SIGLEC7 (0.57) | SIGLEC7MAGNANPSELLSELP | |
| SCHEMBL29883057 | 0.94 | SIGLEC7 (0.57) | SIGLEC7MAGNANPSELLSELP | |
| SCHEMBL14628033 | 0.93 | SELL (0.54) | SIGLEC7MAGNANPSELLSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025088103-A1 | PRODUCTION OF A SIALYLATED COMPOUND | INBIOSE N.V. (BE) | 2025-05-01 | — | — | WO | claimed |
| WO-2025088102-A1 | PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE COMPRISING GAL-β1,3-[NEU5AC-A2,6]-HEXNAC-R | INBIOSE N.V. (BE) | 2025-05-01 | — | — | WO | claimed |
| EP-4742902-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4742899-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4742901-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4743567-A1 | CELLULAR PRODUCTION OF LACTO-N-TRIOSE (LN3)-CONTAINING OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4742900-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4731778-A2 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4704597-A1 | METHOD TO REDUCE FEED CONVERSION RATIO IN A FARMED ANIMAL | Inbiose N.V. (BE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4704598-A1 | FUCOSYLATED MAMMALIAN MILK OLIGOSACCHARIDE FOR USE IN THE PREVENTION OR TREATMENT OF PNEUMONIA | Inbiose N.V. (BE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4704599-A1 | FUCOSYLATED MAMMALIAN MILK OLIGOSACCHARIDE FOR USE IN THE PREVENTION OR TREATMENT OF SHIPPING FEVER | Inbiose N.V. (BE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4192966-A2 | PROCESS FOR PURIFICATION OF AN OLIGOSACCHARIDE SOLUTION PRODUCED BY CELL CULTIVATION OR MICROBIAL FERMENTATION | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | disclosed |
| EP-4192969-A1 | PRODUCTION OF AN OLIGOSACCHARIDE MIXTURE BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | disclosed |
| EP-4192944-A1 | PRODUCTION OF OLIGOSACCHARIDE MIXTURES BY A CELL | Inbiose N.V. (BE) | 2023-06-14 | — | — | EP | disclosed |
| WO-2022219186-A2 | FERMENTATIVE PRODUCTION | INBIOSE N.V. (BE) | 2022-10-20 | — | — | WO | disclosed |
| WO-2022219187-A1 | CELLULAR PRODUCTION OF BIOPRODUCTS | INBIOSE N.V. (BE) | 2022-10-20 | — | — | WO | disclosed |
| WO-2022219188-A1 | CELLULAR PRODUCTION OF SIALYLATED DI- AND/OR OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2022-10-20 | — | — | WO | disclosed |
| WO-2022157213-A1 | PRODUCTION OF OLIGOSACCHARIDES COMPRISING LN3 AS CORE STRUCTURE IN HOST CELLS | INBIOSE N.V. (BE) | 2022-07-28 | — | — | WO | disclosed |
| WO-2022152914-A1 | CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS | INBIOSE N.V. (BE) | 2022-07-21 | — | — | WO | disclosed |
| WO-2022152915-A1 | EXTRACELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS | INBIOSE N.V. (BE) | 2022-07-21 | — | — | WO | disclosed |